These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7657613)

  • 21. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
    Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
    Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The binding sites of inhibitory monoclonal antibodies on acetylcholinesterase. Identification of a novel regulatory site at the putative "back door".
    Simon S; Le Goff A; Frobert Y; Grassi J; Massoulié J
    J Biol Chem; 1999 Sep; 274(39):27740-6. PubMed ID: 10488117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
    Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
    Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes.
    Ashani Y; Radić Z; Tsigelny I; Vellom DC; Pickering NA; Quinn DM; Doctor BP; Taylor P
    J Biol Chem; 1995 Mar; 270(11):6370-80. PubMed ID: 7890775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of oxime reactivators with diethylphosphoryl adducts of human acetylcholinesterase and its mutant derivatives.
    Grosfeld H; Barak D; Ordentlich A; Velan B; Shafferman A
    Mol Pharmacol; 1996 Sep; 50(3):639-49. PubMed ID: 8794905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric control of acetylcholinesterase activity by monoclonal antibodies.
    Saxena A; Hur R; Doctor BP
    Biochemistry; 1998 Jan; 37(1):145-54. PubMed ID: 9425034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate.
    Johnson JL; Cusack B; Davies MP; Fauq A; Rosenberry TL
    Biochemistry; 2003 May; 42(18):5438-52. PubMed ID: 12731886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of 125I-fasciculin to rat brain acetylcholinesterase. The complex still binds diisopropyl fluorophosphate.
    Marchot P; Khélif A; Ji YH; Mansuelle P; Bougis PE
    J Biol Chem; 1993 Jun; 268(17):12458-67. PubMed ID: 8509385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase.
    van den Born HK; Radić Z; Marchot P; Taylor P; Tsigelny I
    Protein Sci; 1995 Apr; 4(4):703-15. PubMed ID: 7613468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II.
    Kryger G; Harel M; Giles K; Toker L; Velan B; Lazar A; Kronman C; Barak D; Ariel N; Shafferman A; Silman I; Sussman JL
    Acta Crystallogr D Biol Crystallogr; 2000 Nov; 56(Pt 11):1385-94. PubMed ID: 11053835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasciculin inhibition of acetylcholinesterase is prevented by chemical modification of the enzyme at a peripheral site.
    Durán R; Cerveñansky C; Dajas F; Tipton KF
    Biochim Biophys Acta; 1994 Dec; 1201(3):381-8. PubMed ID: 7803468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket.
    Ordentlich A; Barak D; Kronman C; Flashner Y; Leitner M; Segall Y; Ariel N; Cohen S; Velan B; Shafferman A
    J Biol Chem; 1993 Aug; 268(23):17083-95. PubMed ID: 8349597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
    Beri V; Wildman SA; Shiomi K; Al-Rashid ZF; Cheung J; Rosenberry TL
    Biochemistry; 2013 Oct; 52(42):7486-99. PubMed ID: 24040835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
    Bui JM; Radic Z; Taylor P; McCammon JA
    Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilization of Torpedo californica acetylcholinesterase by reversible inhibitors.
    Weiner L; Shnyrov VL; Konstantinovskii L; Roth E; Ashani Y; Silman I
    Biochemistry; 2009 Jan; 48(3):563-74. PubMed ID: 19115961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-step analysis as a tool for kinetic parameter estimation and mechanism discrimination in the reaction between tight-binding fasciculin 2 and electric eel acetylcholinesterase.
    Golicnik M; Stojan J
    Biochim Biophys Acta; 2002 May; 1597(1):164-72. PubMed ID: 12009416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural insights into conformational flexibility at the peripheral site and within the active center gorge of AChE.
    Bourne Y; Radić Z; Kolb HC; Sharpless KB; Taylor P; Marchot P
    Chem Biol Interact; 2005 Dec; 157-158():159-65. PubMed ID: 16259971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.
    Bourne Y; Taylor P; Radić Z; Marchot P
    EMBO J; 2003 Jan; 22(1):1-12. PubMed ID: 12505979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
    Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
    J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region.
    Bourne Y; Renault L; Essono S; Mondielli G; Lamourette P; Boquet D; Grassi J; Marchot P
    PLoS One; 2013; 8(10):e77226. PubMed ID: 24146971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.